Table 2.
ICD10 codes that were observed in a significantly higher proportion in the post-COVID window compared to the control window. ICD10 codes that are significant for both non-SDOH and SDOH cohorts are in bold
| ICD10 | Description | Non-SDOH cohort | SDOH cohort | ||||
|---|---|---|---|---|---|---|---|
| Control% | Post% | p-value | Control% | Post% | p-value | ||
| A41 | Other sepsis | 0.667 | 0.813 | 2.0E-26 | 0.684 | 0.761 | 3.9E-07 |
| B49 | Unspecified mycosis | 0.012 | 0.019 | 5.0E-05 | 0.012 | 0.021 | 1.3E-04 |
| B94 | Sequelae of infectious and parasitic diseases | 0.002 | 0.041 | 3.6E-63 | 0.001 | 0.040 | 1.3E-49 |
| D84 | Other immunodeficiencies | 0.036 | 0.052 | 1.1E-06 | 0.043 | 0.058 | 8.4E-05 |
| E43 | Severe protein-calorie malnutrition | 0.126 | 0.214 | 4.8E-40 | 0.131 | 0.204 | 3.5E-23 |
| E44 | Medium/Mild protein-calorie malnutrition | 0.158 | 0.200 | 1.8E-10 | 0.167 | 0.201 | 6.7E-06 |
| E46 | Unspecified protein-calorie malnutrition | 0.148 | 0.232 | 2.4E-33 | 0.144 | 0.224 | 3.9E-25 |
| G72 | Unspecified myopathies | 0.032 | 0.107 | 5.4E-71 | 0.042 | 0.144 | 5.0E-75 |
| G92 | Toxic encephalopathy | 0.090 | 0.112 | 5.0E-06 | 0.093 | 0.111 | 6.9E-04 |
| G93 | Other disorders of brain | 0.702 | 0.847 | 5.6E-25 | 0.702 | 0.846 | 8.7E-20 |
| I26 | Pulmonary embolism | 0.206 | 0.309 | 1.7E-36 | 0.293 | 0.392 | 4.5E-21 |
| I40 | Acute myocarditis | 0.002 | 0.010 | 2.9E-10 | 0.002 | 0.006 | 5.5E-04 |
| I46 | Cardiac arrest | 0.030 | 0.099 | 3.6E-63 | 0.030 | 0.095 | 2.1E-46 |
| I82 | Other venous embolism/thrombosis | 0.419 | 0.484 | 7.2E-10 | 0.539 | 0.574 | 4.9E-03 |
| J12 | Viral pneumonia | 0.055 | 0.938 | 0.0E+ 00 | 0.055 | 1.110 | 0.0E+ 00 |
| J69 | Pneumonitis due to solids and liquids | 0.151 | 0.190 | 2.3E-09 | 0.128 | 0.160 | 1.4E-06 |
| J80 | Acute respiratory distress syndrome | 0.018 | 0.127 | 2.6E-137 | 0.019 | 0.137 | 1.3E-118 |
| J84 | Other interstitial pulmonary diseases | 0.218 | 0.276 | 1.5E-13 | 0.326 | 0.362 | 4.1E-04 |
| J91 | Pleural effusion | 0.036 | 0.049 | 4.6E-05 | 0.041 | 0.053 | 1.3E-03 |
| J93 | Pneumothorax and air leak | 0.036 | 0.067 | 7.9E-18 | 0.040 | 0.070 | 5.4E-13 |
| J95 | Intraoperative/postprocedural complications | 0.043 | 0.072 | 2.8E-14 | 0.040 | 0.072 | 5.0E-14 |
| J96 | Respiratory failure | 1.065 | 1.822 | 0.0E+ 00 | 1.178 | 1.910 | 4.5E-233 |
| K94 | Complications of artificial openings of the digestive system | 0.085 | 0.114 | 9.2E-09 | 0.054 | 0.093 | 4.0E-15 |
| L63 | Alopecia areata | 0.029 | 0.041 | 4.0E-05 | 0.038 | 0.050 | 7.7E-04 |
| L64 | Androgenic alopecia | 0.013 | 0.026 | 9.1E-09 | 0.018 | 0.033 | 3.4E-07 |
| L65 | Telogen effluvium | 0.116 | 0.354 | 3.9E-204 | 0.142 | 0.439 | 5.5E-202 |
| L89 | Pressure ulcer | 0.335 | 0.605 | 3.9E-132 | 0.368 | 0.674 | 2.3E-120 |
| M30 | Polyarteritis nodosa and related conditions | 0.005 | 0.013 | 1.1E-07 | 0.004 | 0.003 | 9.0E-01 |
| O98 | Maternal infectious and parasitic diseases | 0.057 | 0.079 | 2.7E-07 | 0.041 | 0.045 | 1.4E-01 |
| R13 | Aphagia and dysphagia | 1.077 | 1.249 | 1.8E-23 | 1.069 | 1.168 | 1.1E-07 |
| R43 | Disturbances of smell and taste | 0.026 | 0.147 | 1.2E-143 | 0.040 | 0.153 | 2.1E-89 |
| R57 | Shock | 0.052 | 0.095 | 1.1E-23 | 0.054 | 0.089 | 1.2E-13 |
| R64 | Cachexia | 0.032 | 0.047 | 3.3E-06 | 0.033 | 0.045 | 4.7E-04 |
| R65 | Systemic inflammation and infection | 0.238 | 0.320 | 3.2E-22 | 0.256 | 0.304 | 3.2E-07 |
| R77 | Other abnormalities of plasma proteins | 0.042 | 0.077 | 2.2E-19 | 0.048 | 0.084 | 1.3E-14 |
| R78 | Findings of drugs and other substances, not normally found in blood | 0.166 | 0.207 | 2.0E-09 | 0.173 | 0.212 | 3.8E-07 |